Invited Commentary
Commentary on "Successful Use of Intravenous Dexmedetomidine for Magnetic Resonance Imaging Sedation in Autistic Children"
Abstract
In this issue of the Southern Medical Journal, Ahmed and colleagues present their case-control study examining the effectiveness of intravenous dexmedetomidine for achieving deep sedation for magnetic resonance imaging (MRI) among 56 children with an autism spectrum disorder (ASD) compared with 107 children in the control group.1 The authors found that children with ASD could be sedated for MRI successfully using dexmedetomidine and found relatively few significant differences in response between the children with ASD and the control group. Overall, the results provide supportive evidence for implementing this approach in clinical practice and may be a useful guide for clinicians.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.